Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Marasco, S; Simon, AR; Tsui, S; Schramm, R; Eifert, S; Hagl, CM; Paç, M; Kervan, Ü; Fiane, AE; Wagner, FM; Garbade, J; Özbaran, M; Hayward, CS; Zimpfer, D; Schmitto, JD.
International experience using a durable, centrifugal-flow ventricular assist device for biventricular support.
J Heart Lung Transplant. 2020; 39(12): 1372-1379. Doi: 10.1016/j.healun.2020.08.006
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Zimpfer Daniel
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Heart transplantation is limited by the scarcity of suitable donors. Patients with advanced biventricular failure may require biventricular support to provide optimal cardiac output and end-organ perfusion. We highlight the outcomes of using the HeartWare HVAD System (HVAD) in a biventricular configuration. METHODS: This retrospective study included patients implanted with HVAD as a biventricular assist device (BiVAD) between 2009 and 2017 at 12 participating centers. When used as a right ventricular assist device (VAD) (RVAD), the HVAD can be attached to the right ventricle (RV) or the right atrium (RA). Kaplan-Meier survival estimates were calculated comparing the 2 RVAD implant locations. Comparisons were also made between the timing of RVAD implantation (primary vs staged) on adverse event (AE) profiles and survival. RESULTS: Among the 93 patients who were implanted with a HVAD BiVAD, Kaplan-Meier survivals at 1-year and 2-year were 56% and 47%, respectively. Survival was independent of the location of the HVAD RVAD implant or whether there was an interval between left VAD and RVAD implantation. The most common AEs were bleeding (35.5%), infection (25.8%), and respiratory failure (20.4%). CONCLUSIONS: This study illustrated similar survival in patients receiving a primary or staged HVAD BiVAD implant at 1 year and 2 years. This study also established that the locations of the RVAD implant (RV or RA) result in similar AE profiles.
Find related publications in this database (using NLM MeSH Indexing)
Atrial Function, Right - physiology
Follow-Up Studies - administration & dosage
Global Health - administration & dosage
Heart Atria - physiopathology
Heart Failure - mortality, physiopathology, surgery
Heart Ventricles - physiopathology
Heart-Assist Devices - administration & dosage
Humans - administration & dosage
Retrospective Studies - administration & dosage
Survival Rate - trends
Treatment Outcome - administration & dosage
Ventricular Function, Right - physiology

Find related publications in this database (Keywords)
biventricular assist device
biventricular failure
RVAD
BiVAD
HeartWare HVAD BiVAD
© Med Uni GrazImprint